GCF analysis revealed a dysregulated immune profile in T1DM patients, characterized by elevated IL-1 β, IL-6, IL-8 and IL-17A, and reduced levels of IL-2, IL-4, IL-12p70 and IP-10. Here, IL17A is linked to type 1 diabetes mellitus.